Vaccine Therapy in Treating Patients With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: GP2 peptide + GM-CSF vaccine|BIOLOGICAL: GM-CSF (sargramostim)|BIOLOGICAL: AE37 + GM-CSF vaccine|BIOLOGICAL: GM-CSF (sargramostim)
Sponsor: San Antonio Military Medical Center
Collaborators: NuGenerex Immuno-Oncology|Norwell, Inc.